Bifidobacterium longum subsp. longum / Postbiotics Powder

Bifidobacterium longum is recognized as the most prevalent species of bifidobacteria that constitutes a significant component of the gut microbiota in both infants and adults, demonstrating its capability to establish and persist within the human gastrointestinal tract. According to the Bergey's Manual of Systematic Bacteriology, published in 2012, Bifidobacterium longum is categorized into three subspecies: B. longum subsp. longum, B. longum subsp. infantis, and B. longum subsp. porcinum. The safety of Bifidobacterium longum has been acknowledged by reputable authorities, including the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA), while regulatory frameworks in China also endorse its application in food products and dietary supplements. This specific bacterium is pivotal for maintaining human health, displaying various physiological functions such as the prevention and alleviation of constipation, the inhibition of intestinal pathogenic bacteria, the regulation of gut microbiome balance, the reduction of cholesterol levels, the enhancement of nutrient digestion and absorption, the potential delay of aging processes, and the stimulation of immune system activity.